sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Gastrointestinal Drug Market Future Trend Insights, 2024-2030

Global Gastrointestinal Drug Market Future Trend Insights, 2024-2030

Home / Categories / Healthcare
Global Gastrointestinal Drug Market Future Trend Insights, 2024-2030
Global Gastrointestinal Drug Market Future...
Report Code
RO1/135/116672

Publish Date
12/Apr/2024

Pages
212
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table of Content

1 Study Coverage
1.1 Gastrointestinal Drug Product Introduction
1.2 Market by Type
1.2.1 Global Gastrointestinal Drug Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Gastrointestinal Drug Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Gastrointestinal Drug Market by Region
1.4.1 Global Gastrointestinal Drug Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Gastrointestinal Drug Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Gastrointestinal Drug Revenue by Players
2.1.1 Global Gastrointestinal Drug Revenue by Players (2019-2024)
2.1.2 Global Gastrointestinal Drug Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Gastrointestinal Drug Revenue in 2024
2.2 Global Gastrointestinal Drug Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Gastrointestinal Drug Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Takeda Pharmaceuticals
3.1.1 Takeda Pharmaceuticals Information
3.1.2 Takeda Pharmaceuticals Overview
3.1.3 Takeda Pharmaceuticals Gastrointestinal Drug Revenue and Gross Margin (2019-2024)
3.1.4 Takeda Pharmaceuticals Related Developments
3.2 Novo Nordisk A/S
3.2.1 Novo Nordisk A/S Information
3.2.2 Novo Nordisk A/S Overview
3.2.3 Novo Nordisk A/S Gastrointestinal Drug Revenue and Gross Margin (2019-2024)
3.2.4 Novo Nordisk A/S Related Developments
3.3 AstraZeneca Plc
3.3.1 AstraZeneca Plc Information
3.3.2 AstraZeneca Plc Overview
3.3.3 AstraZeneca Plc Gastrointestinal Drug Revenue and Gross Margin (2019-2024)
3.3.4 AstraZeneca Plc Related Developments
3.4 Johnson & Johnson
3.4.1 Johnson & Johnson Information
3.4.2 Johnson & Johnson Overview
3.4.3 Johnson & Johnson Gastrointestinal Drug Revenue and Gross Margin (2019-2024)
3.4.4 Johnson & Johnson Related Developments
3.5 AbbVie Inc. (Allergan Plc)
3.5.1 AbbVie Inc. (Allergan Plc) Information
3.5.2 AbbVie Inc. (Allergan Plc) Overview
3.5.3 AbbVie Inc. (Allergan Plc) Gastrointestinal Drug Revenue and Gross Margin (2019-2024)
3.5.4 AbbVie Inc. (Allergan Plc) Related Developments
3.6 Bausch Health Companies Inc.(Valeant Pharmaceuticals Inc.)
3.6.1 Bausch Health Companies Inc.(Valeant Pharmaceuticals Inc.) Information
3.6.2 Bausch Health Companies Inc.(Valeant Pharmaceuticals Inc.) Overview
3.6.3 Bausch Health Companies Inc.(Valeant Pharmaceuticals Inc.) Gastrointestinal Drug Revenue and Gross Margin (2019-2024)
3.6.4 Bausch Health Companies Inc.(Valeant Pharmaceuticals Inc.) Related Developments
3.7 Bayer AG
3.7.1 Bayer AG Information
3.7.2 Bayer AG Overview
3.7.3 Bayer AG Gastrointestinal Drug Revenue and Gross Margin (2019-2024)
3.7.4 Bayer AG Related Developments
3.8 Boehringer Ingelheim GmbH
3.8.1 Boehringer Ingelheim GmbH Information
3.8.2 Boehringer Ingelheim GmbH Overview
3.8.3 Boehringer Ingelheim GmbH Gastrointestinal Drug Revenue and Gross Margin (2019-2024)
3.8.4 Boehringer Ingelheim GmbH Related Developments
3.9 GlaxoSmithKline Plc.
3.9.1 GlaxoSmithKline Plc. Information
3.9.2 GlaxoSmithKline Plc. Overview
3.9.3 GlaxoSmithKline Plc. Gastrointestinal Drug Revenue and Gross Margin (2019-2024)
3.9.4 GlaxoSmithKline Plc. Related Developments
4 Market Size by Type
4.1 Global Gastrointestinal Drug Revenue by Type
4.2 Global Gastrointestinal Drug Market Size Growth by Type 2019-2024
5 Market Size by Application
5.1 Global Gastrointestinal Drug Revenue by Application
5.2 Global Gastrointestinal Drug Market Size Growth by Application 2019-2024
6 Global Gastrointestinal Drug Market Insights
6.1 Global Gastrointestinal Drug Market Revenue 2019-2024
6.2 Global Gastrointestinal Drug Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Gastrointestinal Drug Market Size by Country
7.1.1 Americas Gastrointestinal Drug Revenue by Country (2019-2024)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Gastrointestinal Drug Market Size by Country
8.1.1 Europe Gastrointestinal Drug Revenue by Country (2019-2024)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Gastrointestinal Drug Market Size by Region
9.1.1 Asia Pacific Gastrointestinal Drug Revenue by Region (2019-2024)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal Drug Market Size by Country
10.1.1 Middle East and Africa Gastrointestinal Drug Revenue by Country (2019-2024)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Gastrointestinal Drug Industry Trends
11.2 Gastrointestinal Drug Market Drivers
11.3 Gastrointestinal Drug Market Challenges
11.4 Gastrointestinal Drug Market Restraints
12 Gastrointestinal Drug Forecasted Market Size by Type
12.1 Global Gastrointestinal Drug Forecasted Revenue by Type
12.2 Global Gastrointestinal Drug Forecasted Market Size Growth by Type 2024-2030
13 Gastrointestinal Drug Forecasted Market Size by Application
13.1 Global Gastrointestinal Drug Forecasted Revenue by Application
13.2 Global Gastrointestinal Drug Forecasted Market Size Growth by Application 2024-2030
14 Global Gastrointestinal Drug Market Forecasts
14.1 Global Gastrointestinal Drug Market Revenue Forecasts 2024-2030
14.2 Global Gastrointestinal Drug Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Gastrointestinal Drug Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Gastrointestinal Drug Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Gastrointestinal Drug Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Gastrointestinal Drug Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com